Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    10573522 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma
Condition: Advanced Hepatocellular Carcinoma
Interventions: Drug: Octreotide-LAR, Lanreotide Autogel;   Other: Locoregional treatments
2 Unknown  Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)
Condition: Carcinoma, Hepatocellular
Intervention: Device: Ablation with the NanoKnife Low Energy Direct Current (LEDC) System

Indicates status has not been verified in more than two years